Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
Evolent Health (NYSE:EVH), a healthcare company focused on complex conditions management, has scheduled its Q2 2025 earnings release for August 7, 2025, after market close. The company will host a conference call at 5:00 PM ET the same day.
Shareholders can access the live broadcast through Evolent's investor relations website. Analysts can participate by dialing 855.940.9467 (US) or 412.317.6034 (International). Additionally, EVH's management team will present at the Canaccord Genuity 44th Annual Growth Conference in Boston on August 13, 2025.
Evolent Health (NYSE:EVH), un'azienda sanitaria specializzata nella gestione di condizioni complesse, ha programmato la pubblicazione dei risultati del secondo trimestre 2025 per il 7 agosto 2025, dopo la chiusura del mercato. La società terrà una conference call alle 17:00 ET dello stesso giorno.
Gli azionisti potranno seguire la trasmissione in diretta tramite il sito web delle relazioni con gli investitori di Evolent. Gli analisti potranno partecipare chiamando il numero 855.940.9467 (USA) o 412.317.6034 (internazionale). Inoltre, il team di gestione di EVH presenterà al Canaccord Genuity 44° Annual Growth Conference a Boston il 13 agosto 2025.
Evolent Health (NYSE:EVH), una empresa de salud enfocada en la gestión de condiciones complejas, ha programado la publicación de sus resultados del segundo trimestre de 2025 para el 7 de agosto de 2025, tras el cierre del mercado. La compañía realizará una llamada conferencia a las 5:00 PM ET ese mismo día.
Los accionistas podrán acceder a la transmisión en vivo a través del sitio web de relaciones con inversores de Evolent. Los analistas pueden participar llamando al 855.940.9467 (EE.UU.) o al 412.317.6034 (internacional). Además, el equipo directivo de EVH presentará en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity en Boston el 13 de agosto de 2025.
Evolent Health (NYSE:EVH)는 복잡한 질환 관리에 중점을 둔 헬스케어 기업으로, 2025년 2분기 실적 발표를 2025년 8월 7일 장 마감 후에 예정하고 있습니다. 회사는 같은 날 동부 표준시 오후 5시에 컨퍼런스 콜을 진행할 예정입니다.
주주들은 Evolent의 투자자 관계 웹사이트를 통해 생중계에 접속할 수 있습니다. 애널리스트들은 미국 내 855.940.9467 또는 국제 전화 412.317.6034로 전화해 참여할 수 있습니다. 또한 EVH 경영진은 2025년 8월 13일 보스턴에서 열리는 Canaccord Genuity 제44회 연례 성장 컨퍼런스에서 발표할 예정입니다.
Evolent Health (NYSE:EVH), une entreprise de santé spécialisée dans la gestion des conditions complexes, a prévu la publication de ses résultats du deuxième trimestre 2025 pour le 7 août 2025, après la clôture des marchés. La société organisera une conférence téléphonique à 17h00 ET le même jour.
Les actionnaires pourront accéder à la diffusion en direct via le site des relations investisseurs d'Evolent. Les analystes peuvent participer en composant le 855.940.9467 (États-Unis) ou le 412.317.6034 (international). De plus, l'équipe de direction d'EVH présentera lors de la 44e conférence annuelle de croissance Canaccord Genuity à Boston le 13 août 2025.
Evolent Health (NYSE:EVH), ein auf die Behandlung komplexer Erkrankungen spezialisiertes Gesundheitsunternehmen, hat die Veröffentlichung der Ergebnisse für das zweite Quartal 2025 für den 7. August 2025 nach Börsenschluss geplant. Am selben Tag wird das Unternehmen um 17:00 Uhr ET eine Telefonkonferenz abhalten.
Aktionäre können die Live-Übertragung über die Investor-Relations-Website von Evolent verfolgen. Analysten können teilnehmen, indem sie die Nummer 855.940.9467 (USA) oder 412.317.6034 (international) wählen. Darüber hinaus wird das Management von EVH am 44. jährlichen Wachstumskonferenz von Canaccord Genuity in Boston am 13. August 2025 teilnehmen und präsentieren.
- None.
- None.
Company to Participate in Upcoming Conferences
Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.
Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.
An audio playback of the conference call will be available on Evolent's investor relations website for 90 days after the call.
Upcoming Investor Events
Additionally, Evolent announced that its executive management team will participate in upcoming investor conferences.
A live audio-only webcast and replay for these events will be available on the "Events and Presentations" section of Evolent's investor relations website. Presentation webcast times will be posted on the website as they become available.
- Canaccord Genuity 44th Annual Growth Conference at the Intercontinental Boston in
Boston, Massachusetts on August 13, 2025
About Evolent
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting https://ir.evolent.com.
Contacts:
investorrelations@evolent.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-to-release-second-quarter-2025-financial-results-on-thursday-august-7-2025-302503580.html
SOURCE Evolent Health, Inc.
FAQ
When will Evolent Health (EVH) release Q2 2025 earnings?
How can investors access Evolent Health's Q2 2025 earnings call?
How long will Evolent Health's Q2 2025 earnings call replay be available?
Where is Evolent Health presenting in August 2025?
